Transcripts APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 02/10/2026			5-day change	1st Jan Change
1,867.00 ^KRW	0.00%		+0.70%	-62.66%

09-23	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
09-03	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI